Leukemia and Lymphoma : Impact Factor & More
eISSN: 1029-2403pISSN: 1042-8194
Share this on:
Key Metrics
CiteScore 
4.2
Impact Factor
< 5
SNIP
0.79
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Leukemia and Lymphoma Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Leukemia and Lymphoma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Leukemia and Lymphoma
Persistent CAR-T signal in delayed immune effector cell-associated enterocolitis following axicabtagene ciloleucel.
- 19 May 2026
- Leukemia & lymphoma
From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.
- 19 May 2026
- Leukemia & lymphoma
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients
- 15 May 2026
- Leukemia & Lymphoma
Flow cytometric analysis of phenotypes and naïve/memory/effector T-cell subsets of T-cell large granular lymphocytic leukemia
- 13 May 2026
- Leukemia & Lymphoma
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM – a single center analysis
- 13 May 2026
- Leukemia & Lymphoma
Integration of peripheral blood lymphocyte count kinetics and bone marrow hematogones for stratifying B-cell recovery and clinical outcomes after cord blood transplantation: a retrospective study
- 12 May 2026
- Leukemia & Lymphoma
Persistent CAR-T signal in delayed immune effector cell-associated enterocolitis following axicabtagene ciloleucel.
- 19 May 2026
- Leukemia & lymphoma
From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.
- 19 May 2026
- Leukemia & lymphoma
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients
- 15 May 2026
- Leukemia & Lymphoma
Flow cytometric analysis of phenotypes and naïve/memory/effector T-cell subsets of T-cell large granular lymphocytic leukemia
- 13 May 2026
- Leukemia & Lymphoma
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM – a single center analysis
- 13 May 2026
- Leukemia & Lymphoma
Integration of peripheral blood lymphocyte count kinetics and bone marrow hematogones for stratifying B-cell recovery and clinical outcomes after cord blood transplantation: a retrospective study
- 12 May 2026
- Leukemia & Lymphoma
FAQs on Leukemia and Lymphoma
How long has Leukemia and Lymphoma been actively publishing? 
What is the publishing frequency of Leukemia and Lymphoma?
How many articles did Leukemia and Lymphoma publish last year?
What is the eISSN & pISSN for Leukemia and Lymphoma?
What is Citescore for Leukemia and Lymphoma?
What is SNIP score for Leukemia and Lymphoma?
Who is the publisher of Leukemia and Lymphoma?
